Evaluation of multimodal treatment program for fibromyalgia
L W Mason1, P Goolkasian, G A McCain
1University of North Carolina, Charlotte, USA.
Journal of Behavioral Medicine
|May 20, 1998
Summary
A multimodal pain treatment program significantly improved psychological well-being and subjective pain in fibromyalgia patients. Long-term benefits were observed, but relapse prevention strategies are needed for sustained fibromyalgia management.
Area of Science:
- Pain Management
- Fibromyalgia Research
- Clinical Psychology
Background:
- Fibromyalgia is a chronic condition characterized by widespread pain and fatigue.
- Current treatment options for fibromyalgia often yield suboptimal results.
- A comprehensive, multimodal approach may offer improved outcomes for fibromyalgia patients.
Purpose of the Study:
- To evaluate the immediate and long-term efficacy of a multimodal pain treatment program for female fibromyalgia patients.
- To compare treatment outcomes with a control group of fibromyalgia patients who did not receive the intervention.
- To assess the impact of the program on both objective (laboratory) and subjective (self-report) pain measures, as well as psychological factors.
Main Methods:
- A quasi-experimental design was employed to assess the multimodal pain treatment program.
- Data collection included laboratory pain measures, self-report pain assessments, and psychological evaluations.
- Patients were assessed up to 6 months post-treatment, with a comparison group of eligible fibromyalgia patients.
Main Results:
- The multimodal program demonstrated significant immediate and long-term positive effects on psychological measures and subjective pain reports.
- Laboratory pain measures did not show significant changes following the intervention.
- Participants completing the month-long program exhibited notable improvements across most outcome metrics.
Conclusions:
- The multimodal pain treatment program is effective in improving psychological well-being and subjective pain in fibromyalgia patients.
- While short-term and some long-term benefits are evident, the lack of change in laboratory pain measures warrants further investigation.
- Future research and clinical practice should prioritize the development and implementation of relapse prevention strategies to ensure sustained benefits for fibromyalgia patients.


